SST and neoplasm: A lengthening of the waiting list (182 [IQR 100–357] vs. 60 [40–88] days, p < 0.001) and increased use of anti-tumor medical treatments (any therapy, peptide receptor radionuclide therapy, and somatostatin analogs; all p < 0.001) was found.